Matt TurnerPatient Affordability
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
Daniel SontupeMarket Access
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
- OBE022 is ObsEva's potential first-in-class, oral and selective PGF2alpha receptor antagonist for the ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email